Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Beam Therapeutics Inc.(BEAM) | 2,266,934 | 2,266,934 | 0 | $56.22M | $44.27M | 75.44% | -$11.95M |
| Lyell Immunopharma, Inc.(LYEL) | 20,162,332 | 20,162,332 | 0 | $12.90M | $10.85M | 18.48% | -$2.06M |
| Prime Medicine, Inc.(PRME) | 1,792,210 | 1,792,210 | 0 | $5.23M | $3.57M | 6.08% | -$1.67M |